CH0012005267 (CH0012005267)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 8/9, Altman Z 3.2 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe equity exhibits robust fundamental economics, characterized by a substantial 9.0% spread between return on invested capital and the weighted average cost of capital, indicating efficient value creation that outpaces financing costs. This operational strength is underpinned by exceptional profitability metrics, including net margins of 24.7% and gross margins near 76%, which drive returns primarily through margin expansion rather than leverage or asset turnover shifts in the DuPont framework. Financial integrity appears high, supported by a Piotroski F-Score of 8/9 suggesting strong financial position improvements, an Altman Z-Score of 3.2 signaling low bankruptcy risk, and a Beneish M-Score of -2.52 that points to minimal earnings manipulation concerns.
Valuation multiples currently sit at 21.3x forward earnings, requiring comparison against historical ranges and sector peers to determine relative positioning, while the implied growth rate embedded in this multiple must be weighed against the company's reported revenue expansion of 9.6%. A discounted cash flow analysis suggests a fair value of $201 per share; comparing this intrinsic estimate directly to current market pricing reveals whether the asset is trading at a premium or discount relative to its calculated present value, with the market effectively pricing in specific future growth assumptions that may differ from historical trends.
The convergence of high profitability scores and low distress metrics creates a favorable risk-reward profile, though the absence of sector-specific Fama-French alpha data limits precision regarding factor exposure. While insider activity remains unquantified in the current dataset, the strong fundamental backdrop suggests resilience against typical value traps often associated with lower quality assets. Investors must determine if the 21.3x multiple adequately compensates for the growth rate and whether the DCF-derived fair value reflects a margin of safety or an overvaluation relative to current trading levels.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 7.6% | 9.6% |
|---|---|---|---|
| 2% | $239 | $169 | $121 |
| 3% | $311 | $201 | $136 |
| 4% | $456 | $251 | $157 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=7.6%, terminal growth 3%. Fair value $201 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell CH0012005267 shares regardless of CH0012005267's individual fundamentals. We estimate $3.9B of passive capital is structurally linked to CH0012005267 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in CH0012005267 to visualize passive redemption contagion across ETFs and collateral stocks.
If CH0012005267 (CH0012005267) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with CH0012005267. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CH0012005267 Ownership Dynamics
ETFs with Highest CH0012005267 Exposure
Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
CH0012005267 Capital Efficiency
How efficiently does CH0012005267 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
CH0012005267 converts 67% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 9.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare CH0012005267 to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.